Cyclosporine A dosing independent of body weight is as safe and effective as is conventional weight-dependent dosing for short-term treatment of severe psoriasis.
Researchers at Johann Wolfgang Goethe University, Christan Albrecht University, Kiel, and Novartis Pharma, all in Germany, and Basel, Switzerland, noted that weight-dependent treatment of psoriasis with cyclosporine A was well established but had recently been reported as unnecessary in treating atopic dermatitis.
That led the researchers to investigate the efficacy and safety of cyclosporine A micro-emulsion given in a new weight-independent protocol and to compare it to a weight-dependent regimen for severe psoriasis.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!